NZ223598A - Zinc-protamine-alpha interferon complexes and pharmaceutical compositions - Google Patents

Zinc-protamine-alpha interferon complexes and pharmaceutical compositions

Info

Publication number
NZ223598A
NZ223598A NZ223598A NZ22359888A NZ223598A NZ 223598 A NZ223598 A NZ 223598A NZ 223598 A NZ223598 A NZ 223598A NZ 22359888 A NZ22359888 A NZ 22359888A NZ 223598 A NZ223598 A NZ 223598A
Authority
NZ
New Zealand
Prior art keywords
protamine
alpha interferon
zinc
pharmaceutical compositions
interferon complexes
Prior art date
Application number
NZ223598A
Other languages
English (en)
Inventor
Z Yim
M A Zupon
I A Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ223598A publication Critical patent/NZ223598A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ223598A 1987-02-24 1988-02-23 Zinc-protamine-alpha interferon complexes and pharmaceutical compositions NZ223598A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/018,243 US4853218A (en) 1987-02-24 1987-02-24 Zinc-protamine-alpha interferon complex

Publications (1)

Publication Number Publication Date
NZ223598A true NZ223598A (en) 1989-12-21

Family

ID=21786960

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223598A NZ223598A (en) 1987-02-24 1988-02-23 Zinc-protamine-alpha interferon complexes and pharmaceutical compositions

Country Status (23)

Country Link
US (1) US4853218A (https=)
EP (2) EP0375678A1 (https=)
JP (1) JPH0611712B2 (https=)
KR (1) KR940001372B1 (https=)
AT (1) ATE76580T1 (https=)
AU (1) AU608584B2 (https=)
CA (1) CA1316105C (https=)
DE (1) DE3871407D1 (https=)
DK (1) DK167048B1 (https=)
ES (1) ES2032009T3 (https=)
FI (1) FI93309C (https=)
GR (1) GR3005358T3 (https=)
HU (1) HU201881B (https=)
IE (1) IE61340B1 (https=)
IL (1) IL85523A (https=)
MX (1) MX9203328A (https=)
MY (1) MY103212A (https=)
NO (1) NO173279C (https=)
NZ (1) NZ223598A (https=)
OA (1) OA09737A (https=)
PT (1) PT86810B (https=)
WO (1) WO1988006456A1 (https=)
ZA (1) ZA881258B (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601741B2 (en) * 1986-05-27 1990-09-20 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ES2054815T3 (es) * 1987-09-08 1994-08-16 Takeda Chemical Industries Ltd Citoquinas insolubilizadas en agua.
WO1991018927A1 (en) * 1990-06-04 1991-12-12 Schering Corporation Method for preparing interferon alpha-2 crystals
US5912015A (en) 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US6514533B1 (en) 1992-06-11 2003-02-04 Alkermas Controlled Therapeutics, Inc. Device for the sustained release of aggregation-stabilized, biologically active agent
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
WO1994012158A1 (en) * 1992-12-02 1994-06-09 Alkermes Controlled Therapeutics, Inc. Controlled release growth hormone containing microspheres
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
AU706180B2 (en) * 1994-07-25 1999-06-10 Alkermes Controlled Therapeutics, Inc. Controlled release of metal cation-stabilized interferon
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
EP0850051A2 (en) * 1995-08-31 1998-07-01 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
ATE203157T1 (de) * 1996-12-20 2001-08-15 Alza Corp Injizierbare depotgelzubereitung und herstellungsverfahren
US6465425B1 (en) * 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
NZ533434A (en) * 2001-11-14 2006-11-30 Alza Corp Thixotropic gel composition for injectable deposition
EP1446100B1 (en) * 2001-11-14 2011-05-04 Durect Corporation Injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
KR20040058101A (ko) * 2001-11-14 2004-07-03 알자 코포레이션 카테터 주입가능한 데포 조성물 및 그의 용도
TWI353854B (en) 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP2006503004A (ja) * 2002-07-31 2006-01-26 アルザ・コーポレーション 射出可能なデポ組成物及びその使用
DE60325742D1 (de) 2002-07-31 2009-02-26 Alza Corp Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
ATE418323T1 (de) * 2002-11-06 2009-01-15 Alza Corp Depot-formulierungen mit verzögerter freisetzung
NZ554885A (en) * 2002-12-31 2009-07-31 Altus Pharmaceuticals Inc Complexes of hgh crystals and protamine polymers
EP2460530A3 (en) * 2002-12-31 2012-08-29 Althea Technologies, Inc. Human growth hormone crystals and methods for preparing them
MXPA05013003A (es) * 2003-05-30 2006-03-17 Alza Corp Composiciones de deposito elastomerico implantables, usos de las mismas y metodo para elaboracion.
US20070184084A1 (en) * 2003-05-30 2007-08-09 Guohua Chen Implantable elastomeric caprolactone depot compositions and uses thereof
US20050106214A1 (en) * 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
US20050281879A1 (en) * 2003-11-14 2005-12-22 Guohua Chen Excipients in drug delivery vehicles
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
US7753077B2 (en) 2007-04-19 2010-07-13 Husco International Inc. Hybrid hydraulic joystick for electrically operating valves
US7753078B2 (en) 2007-04-19 2010-07-13 Husco International Inc. Hybrid hydraulic joystick with an integral pressure sensor and an outlet port
JP4889782B2 (ja) * 2008-12-24 2012-03-07 株式会社マルハニチロ食品 プロタミン及び／またはその塩と酸性高分子化合物とを含む生理活性複合体及びその用途
KR101635689B1 (ko) * 2009-01-28 2016-07-01 스마트쎌스, 인크. 제어 약물 전달을 위한 접합체 기재 시스템
JP2013543898A (ja) * 2010-11-24 2013-12-09 デュレクト コーポレイション 生体分解性薬物送達組成物
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1282504A (fr) * 1954-06-03 1962-01-27 Novo Terapeutisk Labor As Procédé de production de suspensions stables d'insuline zinc-protamine
US3912807A (en) * 1974-04-18 1975-10-14 American Home Prod Treatment of diabetes using somatostatin and insulin
IN150740B (https=) * 1978-11-24 1982-12-04 Hoffmann La Roche
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa

Also Published As

Publication number Publication date
MY103212A (en) 1993-05-29
OA09737A (en) 1993-11-30
NO884596D0 (no) 1988-10-14
FI93309B (fi) 1994-12-15
DE3871407D1 (de) 1992-07-02
KR940001372B1 (ko) 1994-02-21
JPH03500286A (ja) 1991-01-24
NO173279C (no) 1993-11-24
EP0281299B1 (en) 1992-05-27
PT86810B (pt) 1992-05-29
WO1988006456A1 (en) 1988-09-07
ES2032009T3 (es) 1993-01-01
HUT51902A (en) 1990-06-28
FI893929A0 (fi) 1989-08-22
IL85523A0 (en) 1988-08-31
GR3005358T3 (https=) 1993-05-24
IE61340B1 (en) 1994-11-02
ZA881258B (en) 1988-08-23
NO173279B (no) 1993-08-16
US4853218A (en) 1989-08-01
HU201881B (en) 1991-01-28
AU1394688A (en) 1988-09-26
EP0375678A1 (en) 1990-07-04
DK582188D0 (da) 1988-10-19
PT86810A (pt) 1988-03-01
MX9203328A (es) 1992-07-01
DK167048B1 (da) 1993-08-23
IE880480L (en) 1988-08-24
FI893929L (fi) 1989-08-22
KR890700359A (ko) 1989-04-24
AU608584B2 (en) 1991-04-11
FI93309C (fi) 1995-03-27
EP0281299A1 (en) 1988-09-07
IL85523A (en) 1992-11-15
NO884596L (no) 1988-10-14
CA1316105C (en) 1993-04-13
DK582188A (da) 1988-10-19
ATE76580T1 (de) 1992-06-15
JPH0611712B2 (ja) 1994-02-16

Similar Documents

Publication Publication Date Title
NZ223598A (en) Zinc-protamine-alpha interferon complexes and pharmaceutical compositions
NZ224903A (en) C-terminal alpha aminoboronic acid derivatives and pharmaceutical compositions
IL102848A0 (en) Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them
MX171191B (es) Composiciones farmaceuticas de glipizida
IL91706A (en) Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudin
NZ223630A (en) Insulin derivative and pharmaceutical compositions
EP0494972A4 (en) Effervescent dosage form and method of administering same
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
GR3002765T3 (en) New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient
EP0295559A3 (en) Pharmaceutical composition for the treatment of tumors
DE3766885D1 (en) Chlorpheniramine therapie.
EP0468327A3 (en) Oral pharmaceutical compositions containing hirudin
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
ES2016052A6 (es) Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
GB8718805D0 (en) Article for administering medicine
ZA879325B (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon